Toronto Dominion Bank boosted its holdings in shares of Danaher Co. (NYSE:DHR) by 12.7% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 279,439 shares of the conglomerate’s stock after buying an additional 31,460 shares during the quarter. Toronto Dominion Bank’s holdings in Danaher were worth $25,937,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the stock. Point72 Asset Management L.P. increased its holdings in shares of Danaher by 276.8% in the third quarter. Point72 Asset Management L.P. now owns 2,626,865 shares of the conglomerate’s stock valued at $225,332,000 after purchasing an additional 1,929,751 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Danaher by 16,410.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares during the period. Findlay Park Partners LLP grew its holdings in Danaher by 52.9% during the third quarter. Findlay Park Partners LLP now owns 4,117,348 shares of the conglomerate’s stock worth $353,186,000 after acquiring an additional 1,425,000 shares during the period. Koch Industries Inc. grew its holdings in Danaher by 29,127.3% during the second quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock worth $1,388,000 after acquiring an additional 1,399,859 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in Danaher by 86.1% during the third quarter. JPMorgan Chase & Co. now owns 3,011,947 shares of the conglomerate’s stock worth $256,136,000 after acquiring an additional 1,393,165 shares during the period. 75.88% of the stock is currently owned by institutional investors.

Danaher Co. (NYSE DHR) opened at $94.66 on Wednesday. The firm has a market capitalization of $66,070.00, a P/E ratio of 27.14, a PEG ratio of 2.01 and a beta of 1.04. Danaher Co. has a 1 year low of $78.97 and a 1 year high of $104.82. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.43 and a quick ratio of 1.05.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.03. The business had revenue of $5.09 billion for the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.05 earnings per share. sell-side analysts expect that Danaher Co. will post 4.37 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were issued a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 annualized dividend and a dividend yield of 0.59%. Danaher’s dividend payout ratio is presently 16.00%.

DHR has been the topic of several analyst reports. Citigroup raised their target price on Danaher to $107.00 and gave the stock a “buy” rating in a report on Friday, December 15th. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a report on Friday, January 12th. Royal Bank of Canada reaffirmed a “hold” rating and set a $96.00 target price on shares of Danaher in a report on Thursday, January 4th. Stifel Nicolaus raised their target price on Danaher from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Wednesday, January 31st. Finally, Credit Suisse Group raised their target price on Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a report on Friday, October 20th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company. Danaher has an average rating of “Buy” and an average target price of $100.13.

In related news, EVP William K. Daniel sold 131,066 shares of the stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the sale, the executive vice president now owns 270,523 shares of the company’s stock, valued at $27,606,872.15. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the stock in a transaction that occurred on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. In the last ninety days, insiders sold 274,913 shares of company stock valued at $27,729,293. Insiders own 12.20% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This story was reported by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.dailypolitical.com/2018/02/14/danaher-co-dhr-position-lifted-by-toronto-dominion-bank.html.

Danaher Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.